Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001621195 | SCV001845394 | benign | not provided | 2019-12-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001621195 | SCV002356633 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV002272484 | SCV002557907 | benign | Nephrotic syndrome 14 | 2022-06-24 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as benign. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with nephrotic syndrome, type 14 (MIM#617575). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to leucine. (I) 0251 - This variant is heterozygous. (I) 0308 - Population frequency for this variant is out of keeping with known incidence of nephrotic syndrome (gnomAD v2: 22998 heterozygotes, 1586 homozygotes). (SB) 0503 - Missense variant consistently predicted to be tolerated by multiple in silico tools or not conserved in placental mammals with a minor amino acid change. (SB) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0805 - This variant has strong previous evidence of being benign in unrelated individuals. This variant has been classified multiple times as benign (ClinVar, LOVD). (SB) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Breakthrough Genomics, |
RCV001621195 | SCV005321203 | benign | not provided | criteria provided, single submitter | not provided |